Volume 68, Issue 5, Pages (November 2005)

Slides:



Advertisements
Similar presentations
Volume 77, Issue 9, Pages (May 2010)
Advertisements

Perlecan in late stages of osteoarthritis of the human knee joint
The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation  Catherine W. Cheung, David A. Vesey,
Functional Genomics Analysis Reveals a MYC Signature Associated with a Poor Clinical Prognosis in Liposarcomas  Dat Tran, Kundan Verma, Kristin Ward,
Perlecan in late stages of osteoarthritis of the human knee joint
Volume 67, Issue 5, Pages (May 2005)
Osteopontin expression in acute renal allograft rejection
High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer  Jinhong Zhu, Jianqun Ma, Xudong Wang, Tianjiao Ma, Shu Zhang, Wei Wang,
Osteopontin expression in human crescentic glomerulonephritis
Volume 64, Issue 1, Pages (July 2003)
Volume 52, Issue 6, Pages (December 2007)
Y.-H.H. Lien, K.-C. Yong, C. Cho, S. Igarashi, L.-W. Lai 
The Case ∣ Acute renal failure and anemia
Expression of the C-C chemokine receptor 5 in human kidney diseases1
Volume 57, Issue 4, Pages (April 2000)
Volume 140, Issue 1, Pages e2 (January 2011)
Volume 74, Issue 1, Pages (July 2008)
Volume 129, Issue 3, Pages (September 2005)
Volume 63, Issue 6, Pages (June 2003)
Volume 61, Issue 5, Pages (May 2002)
Volume 69, Issue 10, Pages (May 2006)
Volume 63, Issue 1, Pages (January 2003)
Volume 62, Issue 4, Pages (October 2002)
Localization of the prostacyclin receptor in human kidney
Expression of the sodium iodide symporter in human kidney
Thyroid Transcription Factor-1 Amplification and Expressions in Lung Adenocarcinoma Tissues and Pleural Effusions Predict Patient Survival and Prognosis 
Regine Gaetje, M. D. , Uwe Holtrich, Ph. D. , Thomas Karn, Ph. D
Mast cells in human testicular biopsies from patients with mixed atrophy: increased numbers, heterogeneity, and expression of cyclooxygenase 2 and prostaglandin.
Molecular Classification of Renal Tumors by Gene Expression Profiling
Volume 63, Issue 4, Pages (April 2003)
Tubular NF-κB and AP-1 activation in human proteinuric renal disease
Volume 70, Issue 7, Pages (October 2006)
Upregulation of Class II β-Tubulin Expression in Differentiating Keratinocytes  Woong-Hee Lee, Joo-Young Kim, Young-Sik Kim, Hye-Joon Song, Ki-Joon Song,
Volume 60, Issue 1, Pages (July 2001)
Volume 70, Issue 12, Pages (December 2006)
Peritubular capillaritis in the renal allograft takes center stage
Yang Wang, Yi Ping Wang, Yuet-Ching Tay, David C.H. Harris 
Volume 77, Issue 9, Pages (May 2010)
Volume 57, Issue 1, Pages (January 2000)
Volume 67, Issue 4, Pages (April 2005)
Erythropoietin stimulates proliferation of human renal carcinoma cells
A Novel Approach to Detect Programed Death Ligand 1 (PD-L1) Status and Multiple Tumor Mutations Using a Single Non–Small-Cell Lung Cancer (NSCLC) Bronchoscopy.
Volume 55, Issue 2, Pages (February 1999)
Volume 72, Issue 3, Pages (August 2007)
The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation  Catherine W. Cheung, David A. Vesey,
Yongji Wang, Megan L. Borchert, Hector F. DeLuca  Kidney International 
Volume 54, Issue 2, Pages (August 1998)
miR-210 Is a Prognostic Marker in Clear Cell Renal Cell Carcinoma
Volume 65, Issue 3, Pages (March 2004)
Volume 73, Issue 12, Pages (June 2008)
Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin- induced acute kidney injury  K. Negishi, E. Noiri, R. Maeda, D.
Hai Tao Yuan, Su Ping Yang, Adrian Spencer Woolf  Kidney International 
Volume 56, Issue 4, Pages (October 1999)
Volume 55, Issue 1, Pages (January 1999)
Volume 64, Issue 5, Pages (November 2003)
Volume 65, Issue 2, Pages (February 2004)
Volume 65, Issue 1, Pages (January 2004)
Volume 70, Issue 1, Pages (July 2006)
Volume 74, Issue 6, Pages (September 2008)
Volume 80, Issue 5, Pages (September 2011)
Qiong Wu, Kiichiro Jinde, Masayuki Endoh, Hideto Sakai 
HIF activation identifies early lesions in VHL kidneys
Regine Keller-Melchior, Rodney Schmidt, Michael Piepkorn 
Volume 69, Issue 10, Pages (May 2006)
Volume 63, Issue 1, Pages (January 2003)
Cultured human glomerular mesangial cells express the C5a receptor
Volume 58, Issue 6, Pages (December 2000)
A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia–reperfusion injury  L.-W. Lai, K.-C. Yong,
Volume 70, Issue 1, Pages (July 2006)
Volume 57, Issue 1, Pages (January 2000)
Presentation transcript:

Volume 68, Issue 5, Pages 2103-2110 (November 2005) Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissue  Wolfram J. Jabs, Marleen Busse, Stefan Kruger, Dieter Jocham, Jurgen Steinhoff, Christian Doehn  Kidney International  Volume 68, Issue 5, Pages 2103-2110 (November 2005) DOI: 10.1111/j.1523-1755.2005.00666.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Preoperative C-reactive protein (CRP) plasma levels of 40 renal cell carcinoma (RCC) patients in correlation to tumor stage and grade. (A) Tumor stage according to the Union International Contre le Cancer (UICC) classification from 1997[18]. *χ2 = 5.68; P = 0.059 by Kruskal-Wallis test. (B) Tumor grading according to the classification by Thoenes, Störkel, and Rumpelt from 1986[19]. * χ2 = 6.52; P < 0.05 by Kruskal-Wallis test. Kidney International 2005 68, 2103-2110DOI: (10.1111/j.1523-1755.2005.00666.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Frozen sections of renal cell carcinoma (RCC) and surrounding renal tissue as well as Caki cells grown on chamber cultures slides immunostained for C-reactive protein (CRP) using APAAP methodology and naphthole/neofuchsin. Immunoreactivity was examined by monoclonal anti-CRP antibody (Sigma Chemical Co.). (A) Cytoplasmic, homogenous immunoreactivity for CRP in Caki cells (original magnification ×400). (B) Caki cells stained with an irrelevant isotype control antibody (original magnification ×400). (C) Perinuclear staining for CRP in some tumor cells of the viable margin besides tumor cell clusters with intense homogenous coloring (pattern 12, original magnification ×200). (D) Isotype control staining of the tumor margin (pattern 12, original magnification ×200). (E) Detailed view on CRP immunoreactivity in RCC tumor cells with perinuclear staining (←) or bright homogenous (→) coloring (pattern 12, original magnification ×400). (F) CRP immunoreactivity in adjacent renal tissue with perinuclear staining (←) of some tubular epithelial cells and a few more homogenously (→) stained tubules. (→) depicts interstitial cells negative for CRP (pattern 12, original magnification ×100). Kidney International 2005 68, 2103-2110DOI: (10.1111/j.1523-1755.2005.00666.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Detection of C-reactive protein (CRP) mRNA by quantitative multiplex real-time TaqMan™ polymerase chain reaction (PCR). (A) Amplification plots for CRP (left panel) and for hypoxanthine phosphoribosyltransferase (HPRT) (right panel) mRNA detection in tumor center (C1 and C2), tumor margin (C3 and C4), and adjacent tissue (C5 and C6) of pattern 41. Y axis shows the normalized and baseline-corrected reporter signal ΔRn (VIC dye for CRP, FAM dye for HPRT detection), x axis shows the cycle numbers. Note the significantly lower ΔRn values for HPRT, which are due to limited primer/probe concentrations to avoid competition with concurring CRP mRNA amplification. (B) Mean CRP mRNA levels for all 40 renal cell carcinoma (RCC) in tumor centers, margins, and adjacent renal tissues. *P < 0.01 by Wilcoxon test. (C) Mean CRP mRNA levels of the three different tumor regions with regard to tumor grading. Note the particularly strong positive correlation between tumor grade and CRP mRNA levels. **P < 0.01 for tumor center as well as for tumor margin; *P < 0.05 for adjacent kidney. Kidney International 2005 68, 2103-2110DOI: (10.1111/j.1523-1755.2005.00666.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 Subtype-dependent C-reactive protein (CRP) mRNA expression of renal cell carcinoma (RCC) as well as correlation between intratumoral CRP mRNA expression and preoperative CRP plasma levels. (A) Analysis of CRP mRNA levels in the two main different RCC subtypes, clear cell and papillary, revealed significantly elevated levels in clear cell compared to papillary carcinoma. *P < 0.05. n.s. is not significant. (B) CRP mRNA was quantified as described in detail in[3]. CRP mRNA of tumor centers and tumor margins are plotted against respective CRP plasma levels. The given correlations were highly significant, even when corrected for age, gender, and histology of the tumors. Kidney International 2005 68, 2103-2110DOI: (10.1111/j.1523-1755.2005.00666.x) Copyright © 2005 International Society of Nephrology Terms and Conditions